Colin A Depp1, Jenni Ceglowski2, Vicki C Wang2, Faraz Yaghouti2, Brent T Mausbach2, Wesley K Thompson2, Eric L Granholm3. 1. Department of Psychiatry, University of California, San Diego, CA, USA; VA San Diego Healthcare System, USA. Electronic address: cdepp@ucsd.edu. 2. Department of Psychiatry, University of California, San Diego, CA, USA. 3. Department of Psychiatry, University of California, San Diego, CA, USA; VA San Diego Healthcare System, USA.
Abstract
BACKGROUND:Psychosocial interventions for bipolar disorder are frequently unavailable and resource intensive. Mobile technology may improve access to evidence-based interventions and may increase their efficacy. We evaluated the feasibility, acceptability and efficacy of an augmentative mobile ecological momentary intervention targeting self-management of mood symptoms. METHODS: This was a randomized single-blind controlled trial with 82 consumers diagnosed with bipolar disorder who completed a four-session psychoeducational intervention and were assigned to 10 weeks of either: 1) mobile device delivered interactive intervention linking patient-reported mood states with personalized self-management strategies, or 2) paper-and-pencil mood monitoring. Participants were assessed at baseline, 6 weeks (mid-point), 12 weeks (post-treatment), and 24 weeks (follow up) with clinician-rated depression and mania scales and self-reported functioning. RESULTS: Retention at 12 weeks was 93% and both conditions were associated with high satisfaction. Compared to the paper-and-pencil condition, participants in the augmented mobile intervention condition showed significantly greater reductions in depressive symptoms at 6 and 12 weeks (Cohen׳s d for both were d=0.48). However, these effects were not maintained at 24-weeks follow up. Conditions did not differ significantly in the impact on manic symptoms or functional impairment. LIMITATIONS: This was not a definitive trial and was not powered to detect moderators and mediators. CONCLUSIONS:Automated mobile-phone intervention is feasible, acceptable, and may enhance the impact of brief psychoeducation on depressive symptoms in bipolar disorder. However, sustainment of gains from symptom self-management mobile interventions, once stopped, may be limited. Published by Elsevier B.V.
RCT Entities:
BACKGROUND:Psychosocial interventions for bipolar disorder are frequently unavailable and resource intensive. Mobile technology may improve access to evidence-based interventions and may increase their efficacy. We evaluated the feasibility, acceptability and efficacy of an augmentative mobile ecological momentary intervention targeting self-management of mood symptoms. METHODS: This was a randomized single-blind controlled trial with 82 consumers diagnosed with bipolar disorder who completed a four-session psychoeducational intervention and were assigned to 10 weeks of either: 1) mobile device delivered interactive intervention linking patient-reported mood states with personalized self-management strategies, or 2) paper-and-pencil mood monitoring. Participants were assessed at baseline, 6 weeks (mid-point), 12 weeks (post-treatment), and 24 weeks (follow up) with clinician-rated depression and mania scales and self-reported functioning. RESULTS: Retention at 12 weeks was 93% and both conditions were associated with high satisfaction. Compared to the paper-and-pencil condition, participants in the augmented mobile intervention condition showed significantly greater reductions in depressive symptoms at 6 and 12 weeks (Cohen׳s d for both were d=0.48). However, these effects were not maintained at 24-weeks follow up. Conditions did not differ significantly in the impact on manic symptoms or functional impairment. LIMITATIONS: This was not a definitive trial and was not powered to detect moderators and mediators. CONCLUSIONS: Automated mobile-phone intervention is feasible, acceptable, and may enhance the impact of brief psychoeducation on depressive symptoms in bipolar disorder. However, sustainment of gains from symptom self-management mobile interventions, once stopped, may be limited. Published by Elsevier B.V.
Authors: G M Devins; R Dion; L G Pelletier; C M Shapiro; S Abbey; L R Raiz; Y M Binik; P McGowan; N G Kutner; H Beanlands; S M Edworthy Journal: Med Care Date: 2001-10 Impact factor: 2.983
Authors: Colin A Depp; Brent Mausbach; Eric Granholm; Veronica Cardenas; Dror Ben-Zeev; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste Journal: J Nerv Ment Dis Date: 2010-10 Impact factor: 2.254
Authors: K D Denicoff; G S Leverich; W A Nolen; A J Rush; S L McElroy; P E Keck; T Suppes; L L Altshuler; R Kupka; M A Frye; J Hatef; M A Brotman; R M Post Journal: Psychol Med Date: 2000-11 Impact factor: 7.723
Authors: Colin A Depp; John L Stricker; David Zagorsky; Lisa C Goodale; Lisa T Eyler; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste Journal: Community Ment Health J Date: 2008-12-06
Authors: Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic Journal: Psychiatr Serv Date: 2006-07 Impact factor: 3.084
Authors: Dror Ben-Zeev; Christopher J Brenner; Mark Begale; Jennifer Duffecy; David C Mohr; Kim T Mueser Journal: Schizophr Bull Date: 2014-03-08 Impact factor: 9.306
Authors: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Stephen R Wisniewski; Jane N Kogan; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Laszlo Gyulai; Mako Araga; Jodi M Gonzalez; Edwin R Shirley; Michael E Thase; Gary S Sachs Journal: Arch Gen Psychiatry Date: 2007-04
Authors: Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller Journal: Int J Neuropsychopharmacol Date: 2017-02-01 Impact factor: 5.176
Authors: Colin A Depp; Dimitri Perivoliotis; Jason Holden; Jennifer Dorr; Eric L Granholm Journal: Schizophr Bull Date: 2019-06-18 Impact factor: 9.306
Authors: Raeanne C Moore; Christopher N Kaufmann; Alexandra S Rooney; David J Moore; Lisa T Eyler; Eric Granholm; Steven Paul Woods; Joel Swendsen; Robert K Heaton; J C Scott; Colin A Depp Journal: Am J Geriatr Psychiatry Date: 2016-12-01 Impact factor: 4.105
Authors: Susan J Wenze; Michael F Armey; Lauren M Weinstock; Brandon A Gaudiano; Ivan W Miller Journal: J Psychiatr Pract Date: 2016-11 Impact factor: 1.325
Authors: Joseph Firth; John Torous; Jennifer Nicholas; Rebekah Carney; Abhishek Pratap; Simon Rosenbaum; Jerome Sarris Journal: World Psychiatry Date: 2017-10 Impact factor: 49.548
Authors: Julie Kreyenbuhl; Elizabeth J Record; Seth Himelhoch; Melanie Charlotte; Jessica Palmer-Bacon; Lisa B Dixon; Deborah R Medoff; Lan Li Journal: Clin Schizophr Relat Psychoses Date: 2016-07-25